MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Share Price Falls 2.06% Today
- September 1, 2026
- Posted by: Harsh Piplani
- Category: News
MANIPAL HEALTH ENTERPRI L Share Price fell to Rs 746.8 on 01 September 2026, down 2.06% or Rs 15.7 from the previous close of Rs 762.5. The stock opened at Rs 771.7, moved up to an intraday high of Rs 779, and later slipped to a low of Rs 744.55. At this level, the company’s market capitalisation stood at Rs 1,01,527.39 crore, keeping it in the Large Cap bracket within the Healthcare sector.
Today’s move is notable because it came after the stock started the session above the previous close and then reversed lower across the day. The available dataset confirms the price decline and session range, but it does not provide any verified company-specific reason for the move. In such cases, the most useful way to assess the stock is through what the numbers do show: trading range, turnover, valuation, profitability and peer positioning inside the Hospital & Healthcare Services industry.
MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 746.8 |
| Previous Close | Rs 762.5 |
| Today's Move | -Rs 15.70 (-2.06%) |
| Open | Rs 771.7 |
| High | Rs 779 |
| Low | Rs 744.55 |
| Turnover | Rs 2.69 crore |
| Market Capitalisation | Rs 1,01,527.39 crore |
| Market Cap Category | Large Cap |
The intraday structure was weak. After opening at Rs 771.7, the stock briefly touched Rs 779 before falling to Rs 744.55 and then trading near that lower zone at Rs 746.8. That pattern shows that selling pressure overtook the early strength during the session.
For traders and long-term investors alike, the range matters. A decline from the day’s high to the closing reference area can draw attention even in a large company, especially when the stock belongs to a closely watched healthcare segment. Turnover was Rs 2.69 crore, and while the dataset does not state a trigger, it clearly shows a meaningful same-day move.
That is why MANIPAL HEALTH ENTERPRI L Share Price is likely to stay in focus through the session recap: not because a cause is confirmed, but because the stock moved from strength at the open to weakness by afternoon while remaining one of the larger listed names in its industry.
MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,01,527.39 crore |
| P/E Ratio | 112.4x |
| P/B Ratio | 5.5x |
| ROE | 12.95% |
| ROCE | 13.93% |
| EPS | Rs 6.78 |
| Book Value Per Share | Rs 138.69 |
| Dividend Yield | 0% |
The company’s fundamentals present a mix of scale and premium valuation. It carries a market capitalisation of Rs 1,01,527.39 crore, a P/E ratio of 112.4 and a P/B ratio of 5.5. Profitability metrics show ROE at 12.95% and ROCE at 13.93%, while EPS is Rs 6.78 and book value per share is Rs 138.69. The dividend yield in the supplied data is 0%.
The main takeaway is valuation. A P/E of 112.4 means the stock is trading at more than 112 times earnings, which is a demanding multiple in absolute terms. A P/B of 5.5 also suggests investors are valuing the company well above its accounting book value. These ratios do not by themselves prove overvaluation or undervaluation, but they do indicate that the stock is being priced with a premium relative to earnings and net worth.
Profitability is steadier than spectacular based on the supplied numbers. ROE of 12.95% and ROCE of 13.93% point to moderate return generation, while When a stock with these characteristics sees a one-day decline, investors often compare whether the valuation premium is supported by relative returns versus peers. That makes the industry benchmark especially important for reading MANIPAL HEALTH ENTERPRI L Share Price in context.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 112.4x |
| Benchmark Median P/E | 47.88x |
| Benchmark Average P/E | 103.86x |
| Benchmark P/E Range | 7.74x to 1,515.36x |
| Company P/B Ratio | 5.5x |
| Benchmark Median P/B | 4.17x |
| Benchmark Average P/B | 4.72x |
| Company ROE | 12.95% |
| Benchmark Median ROE | 12.82% |
| Benchmark Average ROE | 13.8% |
| Company ROCE | 13.93% |
| Benchmark Median ROCE | 15.7% |
| Benchmark Average ROCE | 3.09% |
| Company Market Capitalisation | Rs 1,01,527.39 crore |
| Benchmark Median Market Cap | Rs 742.29 crore |
| Benchmark Average Market Cap | Rs 12,193.75 crore |
The company operates in Healthcare under Hospital & Healthcare Services. In the same-industry benchmark, its P/E of 112.4 is well above the median of 47.88 and modestly above the average of 103.86. The industry P/E range is very wide, from 7.74 to 1,515.36, so the stock is not at the top end of the range, but it still screens as a premium-priced name versus much of the field.
Its P/B ratio of 5.5 is also above the industry median of 4.17 and average of 4.72. On returns, ROE of 12.95% is slightly above the median of 12.82% but below the average of 13.8, while ROCE of 13.93% is below the median of 15.7. These figures suggest that valuation sits above benchmark norms more clearly than profitability does.
Scale is the other major differentiator. The company’s market cap of Rs 1,01,527.39 crore is far above the industry median market cap of Rs 742.29 crore and the industry average of Rs 12,193.75 crore. That gap highlights how unusually large the company is within its listed industry set. In other words, MANIPAL HEALTH ENTERPRI L Share Price reflects a business whose size is clearly superior to the typical industry participant, even though its return metrics are closer to the middle of the peer distribution.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise | APOLLOHOSP | 1,27,187.59 | 60.97 | 13.15 | 23.54 | 21.73 |
| Max Healthcare Institute | MAXHEALTH | 98,597.77 | 68.07 | 9.08 | 14.53 | 14.97 |
| Fortis Healthcare | FORTIS | 70,211.11 | 65.42 | 6.75 | 11.32 | 14.07 |
| Aster DM Healthcare | ASTERDM | 64,952.67 | 206.73 | 13.26 | 9.32 | 11.46 |
| Global Health | MEDANTA | 39,537.6 | 71.66 | 9.69 | 15.12 | 19.38 |
Among major listed peers, the company is one of the largest. Its market cap is below Apollo Hospitals at Rs 1,27,187.59 crore but above Max Healthcare at Rs 98,597.77 crore, Fortis at Rs 70,211.11 crore, Aster DM Healthcare at Rs 64,952.67 crore and Global Health at Rs 39,537.6 crore.
On earnings multiples, the stock stands at 112.4 times earnings, which is higher than Apollo Hospitals at 60.97, Max Healthcare at 68.07, Fortis at 65.42 and Global Health at 71.66. Only Aster DM Healthcare, at 206.73, trades on a higher P/E in this comparison set. On P/B, the company’s 5.5 is below Apollo’s 13.15, Max’s 9.08, Aster’s 13.26 and Global Health’s 9.69, and also below Fortis at 6.75.
Returns are mixed relative to these peers. ROE of 12.95% is below Apollo’s 23.54%, Max’s 14.53% and Global Health’s 15.12%, but above Fortis at 11.32% and Aster at 9.32%. ROCE of 13.93% is below Apollo, Max, Fortis and Global Health, while still above Aster. This means the peer picture is not one of simple weakness or strength; instead, it shows a company with significant scale, a high P/E versus several peers, and profitability that sits in the middle rather than at the top of the set. That mix helps explain why MANIPAL HEALTH ENTERPRI L Share Price remains closely watched during a down session.
Why Investors Are Watching the Stock
- The stock fell 2.06% to Rs 746.8 and traded close to the day’s low of Rs 744.55.
- It remains a Large Cap healthcare name with market capitalisation of Rs 1,01,527.39 crore.
- The P/E ratio of 112.4 is above the industry median of 47.88 and average of 103.86.
- ROE of 12.95% and ROCE of 13.93% are respectable, but they do not clearly dominate the major peer set.
- The dataset confirms the price move but does not confirm a company-specific catalyst, keeping attention on valuation and relative positioning.
About MANIPAL HEALTH ENTERPRI L
The company is classified in the Healthcare sector and Hospital & Healthcare Services industry. Based on the supplied peer set, it is grouped alongside listed names such as Apollo Hospitals Enterprise, Max Healthcare Institute, Fortis Healthcare, Aster DM Healthcare and Global Health
That classification matters because sector context shapes how investors read daily moves. In a hospital-services stock, scale, return ratios and valuation often carry more weight than a single session in isolation. Even after today’s fall, MANIPAL HEALTH ENTERPRI L Share Price is still best understood through those broader comparisons rather than through price action alone.
Track MANIPAL HEALTH ENTERPRI L Share Price on Univest
Use MANIPAL HEALTH ENTERPRI L (MANIPALHOS) live share-price page,Univest top decliners screener,Univest market blogsto review live stock data, top decliners and related market analysis.
Investors tracking MANIPAL HEALTH ENTERPRI L Share Price can use these pages to monitor price movement, valuation metrics, profitability ratios and sector context in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did MANIPAL HEALTH ENTERPRI L Share Price fall today?
Ans. The stock fell 2.06% to Rs 746.8, down Rs 15.7 from the previous close of Rs 762.5. The supplied data confirms the move, but it does not identify a company-specific reason.
What is MANIPAL HEALTH ENTERPRI L Share Price today?
Ans. MANIPAL HEALTH ENTERPRI L Share Price today is Rs 746.8. During the session, the stock opened at Rs 771.7, hit a high of Rs 779 and a low of Rs 744.55.
How expensive is the stock on a P/E basis?
Ans. The stock trades at a P/E ratio of 112.4, which is above the same-industry median of 47.88 and the average of 103.86. The company trades at a P/E ratio of 112.4x.
What are the key profitability numbers?
Ans. The company reports ROE of 12.95% and ROCE of 13.93%. ROE is slightly above the industry median of 12.82%, while ROCE is below the industry median of 15.7. ROE stands at 12.95%.
How does it compare with Apollo Hospitals and Max Healthcare?
Ans. Its market cap is below Apollo Hospitals but above Max Healthcare. Its P/E of 112.4 is higher than Apollo’s 60.97 and Max Healthcare’s 68.07. Comparable listed companies include Apollo Hospitals Enterprise, Max Healthcare Institute, Fortis Healthcare.
